These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 30977191)

  • 1. T-cell positioning by chemokines in autoimmune skin diseases.
    Richmond JM; Strassner JP; Essien KI; Harris JE
    Immunol Rev; 2019 May; 289(1):186-204. PubMed ID: 30977191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoreactive T-Lymphocytes in Inflammatory Skin Diseases.
    Boehncke WH; Brembilla NC
    Front Immunol; 2019; 10():1198. PubMed ID: 31191553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector T cell differentiation: are master regulators of effector T cells still the masters?
    Wang C; Collins M; Kuchroo VK
    Curr Opin Immunol; 2015 Dec; 37():6-10. PubMed ID: 26319196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine tuning subsets of CD4
    Zhao Z; Zhang X; Su L; Xu L; Zheng Y; Sun J
    Int Immunopharmacol; 2018 Mar; 56():269-276. PubMed ID: 29414661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic modulation of cutaneous autoimmunity by regulatory T cells.
    Loser K; Beissert S
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii20-2. PubMed ID: 16987825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of chemokines in the recruitment of lymphocytes to the liver.
    Oo YH; Adams DH
    J Autoimmun; 2010 Feb; 34(1):45-54. PubMed ID: 19744827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine axis as a therapeutic target to enhance the recruitment of Tregs and treat organ-specific autoimmune and inflammatory diseases.
    Bayry J
    Immunotherapy; 2012 Jan; 4(1):9-12. PubMed ID: 22149994
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking.
    Comerford I; Kara EE; McKenzie DR; McColl SR
    Br J Haematol; 2014 Feb; 164(3):329-41. PubMed ID: 24164387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Treg signaling for the treatment of autoimmune diseases.
    Spence A; Klementowicz JE; Bluestone JA; Tang Q
    Curr Opin Immunol; 2015 Dec; 37():11-20. PubMed ID: 26432763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-induced regulatory T cells in autoimmunity.
    von Herrath MG; Harrison LC
    Nat Rev Immunol; 2003 Mar; 3(3):223-32. PubMed ID: 12658270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cellular immunity in the pathogenesis of autoimmune skin diseases.
    Alaibac M; Berti E; Chizzolini C; Fineschi S; Marzano AV; Pigozzi B; Riboldi E; Sozzani S; Kuhn A
    Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S14-9. PubMed ID: 16466620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in autoimmune diseases.
    Arimilli S; Ferlin W; Solvason N; Deshpande S; Howard M; Mocci S
    Immunol Rev; 2000 Oct; 177():43-51. PubMed ID: 11138783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy.
    Nicolson KS; Wraith DC
    Inflamm Allergy Drug Targets; 2006 Sep; 5(3):141-8. PubMed ID: 16918477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Getting Under the Skin: Targeting Cutaneous Autoimmune Disease.
    Vesely MD
    Yale J Biol Med; 2020 Mar; 93(1):197-206. PubMed ID: 32226348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
    George J
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1-induced regulatory T cells.
    Hadaschik EN; Enk AH
    Hum Immunol; 2015 Aug; 76(8):561-4. PubMed ID: 26116540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactive T-Cell subsets in acute and chronic syngeneic graft-versus-host disease.
    Hess A; Thoburn C; Chen W; Horwitz L
    Transplant Proc; 2001; 33(1-2):1754-6. PubMed ID: 11267499
    [No Abstract]   [Full Text] [Related]  

  • 18. PKC-θ function at the immunological synapse: prospects for therapeutic targeting.
    Zanin-Zhorov A; Dustin ML; Blazar BR
    Trends Immunol; 2011 Aug; 32(8):358-63. PubMed ID: 21733754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases.
    Cravens PD; Lipsky PE
    Immunol Cell Biol; 2002 Oct; 80(5):497-505. PubMed ID: 12225387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
    Stinissen P; Raus J; Zhang J
    Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.